💉 EMA has recommended the use of Novavax’s #COVID19vaccine, Nuvaxovid, in adolescents aged 12 to 17 years.
#PandemicResponse #PublicHealth #VaccinesWork
👉 https://www.ema.europa.eu/en/news/ema-recommends-authorisation-nuvaxovid-adolescents-aged-12-17